|
|
|
|
LEADER |
05922nam a2201021Ia 4500 |
001 |
10.1186-s41021-021-00186-2 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 18807046 (ISSN)
|
245 |
1 |
0 |
|a Mass spectrometric profiling of DNA adducts in the human stomach associated with damage from environmental factors
|
260 |
|
0 |
|b BioMed Central Ltd
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1186/s41021-021-00186-2
|
520 |
3 |
|
|a Background: A comprehensive understanding of DNA adducts, one of the most plausible origins of cancer mutations, is still elusive, especially in human tissues in clinical settings. Recent technological developments have facilitated the identification of multiple DNA adducts in a single experiment. Only a few attempts toward this “DNA adductome approach” in human tissues have been reported. Geospatial information on DNA adducts in human organs has been scarce. Aim: Mass spectrometry of human gastric mucosal DNA was performed to identify DNA adducts associated with environmental factors. Materials and methods: From 59 subjects who had received gastrectomy for gastric cancer, 306 samples of nontumor tissues and 15 samples of tumors (14 cases) were taken for DNA adductome analysis. Gastric nontumor tissue from autopsies of 7 subjects without gastric cancer (urothelial cancer, hepatocellular carcinoma, lung cancer each; the other four cases were without any cancers) was also investigated. Briefly, DNA was extracted from each sample with antioxidants, digested into nucleosides, separated by liquid chromatography, and then electrospray-ionized. Specific DNA adducts were identified by mass/charge number and column retention time compared to standards. Information on lifestyle factors such as tobacco smoking and alcohol drinking was taken from the clinical records of each subject. Results: Seven DNA adducts, including modified bases, C5-methyl-2′-deoxycytidine, 2′-deoxyinosine, C5-hydroxymethyl-2′-deoxycytidine, N6-methyl-2′-deoxyadenosine, 1,N6-etheno-2′-deoxyadenosine, N6-hydroxymethyl-2′-deoxyadenosine, and C8-oxo-2′-deoxyguanosine, were identified in the human stomach and characterized. Intraindividual differences according to the multiple sites of these adducts were noted but were less substantial than interindividual differences. N6-hydroxymethyl-2′-deoxyadenosine was identified in the human stomach for the first time. The amount of C5-hydroxymethyl-2′-deoxycytidine was higher in the stomachs of subjects without gastric cancer than in the nontumor and tumor portions of the stomach in gastric cancer patients. Higher levels of 1,N6-etheno-2′-deoxyadenosine were detected in the subjects who reported both smoking and drinking than in those without these habits. These DNA adducts showed considerable correlations with each other. Conclusions: We characterized 7 DNA adducts in the nontumor portion of the human stomach in both gastric cancer subjects and nongastric cancer subjects. A reduction in C5-hydroxymethyl-dC even in the nontumor mucosa of patients with gastric cancer was observed. Smoking and drinking habits significantly influenced the quantity of one of the lipid peroxidation-derived adducts, etheno-dA. A more expansive DNA adductome profile would provide a comprehensive understanding of the origin of human cancer in the future. © 2021, The Author(s).
|
650 |
0 |
4 |
|a 1,n6 etheno 2' deoxyadenosine
|
650 |
0 |
4 |
|a adductomics
|
650 |
0 |
4 |
|a aged
|
650 |
0 |
4 |
|a antioxidant
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a autopsy
|
650 |
0 |
4 |
|a c5 hydroxymethyl 2' deoxycytidine
|
650 |
0 |
4 |
|a c5 methyl 2' deoxycytidine
|
650 |
0 |
4 |
|a c8 oxo 2' deoxyguanosine
|
650 |
0 |
4 |
|a carcinogenesis
|
650 |
0 |
4 |
|a comparative study
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a deoxyadenosine
|
650 |
0 |
4 |
|a deoxycytidine
|
650 |
0 |
4 |
|a deoxyinosine
|
650 |
0 |
4 |
|a disease association
|
650 |
0 |
4 |
|a DNA
|
650 |
0 |
4 |
|a DNA adduct
|
650 |
0 |
4 |
|a DNA adduct
|
650 |
0 |
4 |
|a DNA adductome
|
650 |
0 |
4 |
|a DNA adductomics
|
650 |
0 |
4 |
|a DNA damage
|
650 |
0 |
4 |
|a DNA determination
|
650 |
0 |
4 |
|a DNA extraction
|
650 |
0 |
4 |
|a DNA fingerprinting
|
650 |
0 |
4 |
|a drinking behavior
|
650 |
0 |
4 |
|a electrospray mass spectrometry
|
650 |
0 |
4 |
|a environmental factor
|
650 |
0 |
4 |
|a enzymatic hydrolysis
|
650 |
0 |
4 |
|a Exposure
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a gastrectomy
|
650 |
0 |
4 |
|a Gastric cancer
|
650 |
0 |
4 |
|a genomic DNA
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a human tissue
|
650 |
0 |
4 |
|a lifestyle modification
|
650 |
0 |
4 |
|a liquid chromatography
|
650 |
0 |
4 |
|a Liquid chromatography/tandem mass spectrometry
|
650 |
0 |
4 |
|a liquid chromatography-mass spectrometry
|
650 |
0 |
4 |
|a liver cell carcinoma
|
650 |
0 |
4 |
|a lung cancer
|
650 |
0 |
4 |
|a lymph node metastasis
|
650 |
0 |
4 |
|a major clinical study
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a mass spectrometry
|
650 |
0 |
4 |
|a Mutagen
|
650 |
0 |
4 |
|a n6 hydroxymethyl 2' deoxyadenosine
|
650 |
0 |
4 |
|a n6 methyl 2' deoxyadenosine
|
650 |
0 |
4 |
|a nucleoside
|
650 |
0 |
4 |
|a retention time
|
650 |
0 |
4 |
|a ribonuclease A
|
650 |
0 |
4 |
|a smoking
|
650 |
0 |
4 |
|a Stomach
|
650 |
0 |
4 |
|a stomach cancer
|
650 |
0 |
4 |
|a stomach injury
|
650 |
0 |
4 |
|a stomach mucosa
|
650 |
0 |
4 |
|a transitional cell carcinoma
|
650 |
0 |
4 |
|a unclassified drug
|
700 |
1 |
|
|a Fukazawa, A.
|e author
|
700 |
1 |
|
|a Inaba, K.
|e author
|
700 |
1 |
|
|a Iwashita, Y.
|e author
|
700 |
1 |
|
|a Kurono, N.
|e author
|
700 |
1 |
|
|a Matsumoto, K.
|e author
|
700 |
1 |
|
|a Matsushima, Y.
|e author
|
700 |
1 |
|
|a Matsushita, Y.
|e author
|
700 |
1 |
|
|a Mori, H.
|e author
|
700 |
1 |
|
|a Ochiai, H.
|e author
|
700 |
1 |
|
|a Ohnishi, I.
|e author
|
700 |
1 |
|
|a Ohtsuka, S.
|e author
|
700 |
1 |
|
|a Sugimura, H.
|e author
|
700 |
1 |
|
|a Suzuki, S.
|e author
|
700 |
1 |
|
|a Suzuki, S.
|e author
|
700 |
1 |
|
|a Tanioka, F.
|e author
|
700 |
1 |
|
|a Yamashita, T.
|e author
|
773 |
|
|
|t Genes and Environment
|